Article Text
Statistics from Altmetric.com
A H MacLennan
Dr A H MacLennan, University of Adelaide, Adelaide, South Australia, Australia; alastair.maclennan@adelaide.edu.au
STUDY DESIGN
Design:
randomised controlled trial (Women’s International Study of long Duration Oestrogen after Menopause [WISDOM]).
Allocation:
concealed.*
Blinding:
blinded ({patients, healthcare providers}†, and outcome assessors).*
Setting:
384 general practices in the UK, 91 in Australia, and 24 in New Zealand.
STUDY QUESTION
Patients:
5692 women, 50–69 years of age (mean age 63 y), who were postmenopausal and achieved 80% compliance during a 12-week run-in period. Exclusion criteria included previous breast cancer; cancer other than basal or squamous cell skin cancer within the past 10 years; endometriosis or endometrial hyperplasia; venous thromboembolism (VTE); current gall stones; and ⩾1 of the following within the past 6 months—myocardial infarction (MI), unstable angina, cerebrovascular accident, subarachnoid haemorrhage, transient ischaemic attack, or …
Footnotes
Source of funding: no funding was provided by industry.
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.